Health Care: Drugs

Apricus Biosciences Inc (APRI: NASDAQ)

$1.56 n/a | n/a%
10/21/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 2.51M 8.42M 4.10M 4.97M
Cost of Sales 2.30M 12.57M 1.60M 4.40M
Gross Operating Profit 207.00K -4.15M 2.50M 577.01K
Selling, General, and Administrative Expenses 13.55M 15.38M 11.46M 10.15M
Research & Development 5.12M 5.38M 5.82M 2.11M
Operating Income before D & A (EBITDA) -18.47M -24.90M -14.78M -11.69M
Depreciation & Amortization 327.00K 240.00K 639.47K 9.72M
Interest Income 0.00 0.00 13.73K 28.02K
Other Income - Net 3.65M 425.00K -2.33M 715.08K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -15.14M -24.72M -17.74M -20.66M
Interest Expense 727.00K 325.00K 376.92K 8.85M
Pre-Tax Income -15.87M -25.04M -18.12M -29.51M
Income Taxes 0.00 516.00K 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -15.87M -25.56M -18.12M -29.51M
Net Income From Discontinued Operations -1.07M -6.21M 0.00 0.00
Net Income From Total Operations -16.94M -31.77M -18.12M -29.51M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -16.94M -31.77M -18.12M -29.51M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-15.87M -25.56M -18.12M -29.51M
Preferred Dividends
Net Income Available To Common -15.87M -25.56M -18.12M -29.51M
Basic EPS from Continuing Ops. -0.46 -0.93 -0.90 -2.49
Basic EPS from Discontinued Ops. -0.03 -0.23 0.00 0.00
Basic EPS from Total Operations -0.49 -1.16 -0.90 -2.49
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.49 -1.16 -0.90 -2.49
Basic Normalized Net Income/Share -0.46 -0.93 -0.90 -2.49
EPS fr Continuing Ops. -0.46 -0.93 -0.90 -2.49
EPS fr Discontinued Ops -0.03 -0.23 0.00 0.00
EPS fr Total Ops. -0.49 -1.16 -0.90 -2.49
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.49 -1.16 -0.90 -2.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.46 -0.93 -0.90 -2.49
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with APRI

Latest APRI Headlines from TheStreet

More Financial News for APRI

Press Releases for APRI

See All Press Releases

Partner Headlines for APRI

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter